Low magnification electron micrograph of a monkey kidney cell (Vero E6) after infection with the SARS-CoV-2 Omicron variant showing cell damage with swollen vesicles containing small black viral particles.
(Right) High magnification electron micrograph of an infected Vero E6 cell showing aggregates of viral particles with corona shaped spikes on their surface (red box).
Meanwhile, Omicron can be neutralized by three doses of Pfizer, the press center of Pfizer reports.
"Pfizer Inc. and BioNTech today announced results from an initial laboratory study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses," the message reads.
It is noted that two doses of the vaccine may not be enough to protect against infection with the Omicron strain, and the third dose of Pfizer increases the amount of antibodies in the human body by 25 times.
It is stated that the third dose provides a similar level of neutralization of antibodies to Omicron, as observed after two doses against other strains of the virus that appeared before the new variant of the disease.